NARAYANA HRUDAYALAYA Q2FY26 CON CALL

India Hospitals

  • ~20% EBITDA growth driven by better case-mix and payor-mix, not pricing.
  • Govt share (18–20%) keeps ARPP flat.
  • Strong robotic surgery growth; shift to shorter LOS.
  • International patient business being wound down.

CGHS Tariff Hike

  • Package rates +30%, non-package +12%.
  • ~1% revenue uplift; 70–80% flows to EBITDA.
  • Adds INR 2–2.5 crore per month.

Mumbai (SRCC)

  • Slightly negative EBITDA; Q3 likely positive.
  • Moving from pediatric-only to mixed adult + pediatric care.

Cayman

  • Hospital margin 43–44%; a few quarters of growth left.
  • Insurance growing fast but profitability volatile.

UK (Practice Plus)

  • Consolidation from Q3.
  • 90–93% revenue secured via NHS.
  • Big upside from increasing private mix (now 7–8%).

Integrated Care (India)

  • Retail + SME traction; losses narrowing.

Digital/AI

  • Early software commercialization; internal usage priority.

CapEx

  • Focus on productivity from existing beds; disciplined India capex rollout.

Leave a Reply

Your email address will not be published. Required fields are marked *